CAS 153537-73-6: Plevitrexed

Description: Plevitrexed, with the CAS number 153537-73-6, is a synthetic compound classified as an antifolate and is primarily used in the treatment of certain types of cancer, particularly mesothelioma and non-small cell lung cancer. It functions as a potent inhibitor of dihydrofolate reductase (DHFR), an enzyme critical for DNA synthesis and cell division, thereby impeding the proliferation of cancer cells. Plevitrexed is characterized by its structural similarity to folate, allowing it to effectively compete with natural substrates for binding to DHFR. The compound is typically administered intravenously and is often used in combination with other chemotherapeutic agents to enhance therapeutic efficacy. Its pharmacokinetics involve metabolism primarily in the liver, with renal excretion of metabolites. Side effects may include myelosuppression, gastrointestinal disturbances, and potential hypersensitivity reactions. Due to its mechanism of action, Plevitrexed is an important agent in oncological pharmacotherapy, contributing to improved outcomes in patients with specific malignancies.

Formula: C₂₆H₂₅FN₈O₄

InChI: InChI=1S/C26H25FN8O4/c1-4-9-35(13-16-11-19-22(10-14(16)2)28-15(3)29-25(19)37)17-5-6-18(20(27)12-17)24(36)30-21(26(38)39)7-8-23-31-33-34-32-23/h1,5-6,10-12,21H,7-9,13H2,2-3H3,(H,30,36)(H,38,39)(H,28,29,37)(H,31,32,33,34)/t21-/m0/s1

InChI key: InChIKey=IEJSCSAMMLUINT-NRFANRHFSA-N

SMILES: O=C1N=C(NC=2C=C(C(=CC12)CN(C3=CC=C(C(=O)NC(C(=O)O)CCC4=NN=NN4)C(F)=C3)CC#C)C)C

Synonyms:

• (2S)-2-((4-(((2,7-Dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)(prop-2-ynyl)amino)-2-fluorobenzoyl)amino)-4-(1H-tetrazol-5-yl)butanoic acid
• (2S)-2-[(4-{[(2,7-dimethyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl](prop-2-yn-1-yl)amino}-2-fluorobenzoyl)amino]-4-(2H-tetrazol-5-yl)butanoic acid
• (aS)-a-[[4-[[(1,4-Dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-1H-tetrazole-5-butanoic Acid
• 1H-Tetrazole-5-butanoic acid, α-[[4-[[(1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-, (S)-
• 1H-Tetrazole-5-butanoic acid, α-[[4-[[(1,4-dihydro-2,7-dimethyl-4-oxo-6-quinazolinyl)methyl]-2-propynylamino]-2-fluorobenzoyl]amino]-, (αS)-
• Bgc 9331
• Fluorobenzamido)-4-(1H-Tetrazol-5-Yl)Butyric Acid
• Nsc 696259
• Vamidex
• Zd 9331
• Plevitrexed

Plevitrexed

CAS: 153537-73-6

• Formula: C₂₆H₂₅FN₈O₄
• Color and Shape: Neat
• Molecular weight: 532.53

Plevitrexed

CAS: 153537-73-6

Plevitrexed, an oral TS inhibitor (Ki: 0.44 nM), targets α-folate receptor & reduced folate carrier, …

• Formula: C₂₆H₂₅FN₈O₄
• Purity: 98%
• Color and Shape: Solid
• Molecular weight: 532.53

Plevitrexed

CAS: 153537-73-6

Plevitrexed is a prodrug that is converted in the body to its active form, pemetrexed. …

• Formula: C₂₆H₂₅FN₈O₄
• Purity: Min. 95%
• Molecular weight: 532.53 g/mol